Gene · 100187828
HBD: hypophosphatemic bone disease
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. HBD: hypophosphatemic bone disease. Genes, record 100187828. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/100187828
On this page
Gene
- Symbol
- HBD
- Name
- hypophosphatemic bone disease
- NCBI Gene ID
- 100187828
- Type
- unknown
Source NCBI Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants914
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HBD papers | Newest fiscal year |
|---|---|---|---|
| R01DK111430 | Molecular Analysis of Transcriptional Enhancers in Hematopoiesis | 6 | 2025 |
| R01HL119479 | Regulation of Hemoglobin Switching | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| U54DK106829 | Stem Cell and Transplantation Biology | 4 | 2025 |
| R01DK103794 | Systematic Genetic Dissection of Human Erythropoiesis | 3 | 2025 |
| U24CA224319 | High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials | 3 | 2025 |
| K08DK129716 | Cellular Signaling Pathways in the Regulation of Fetal Hemoglobin for Treatment of Sickle Cell Disease | 2 | 2025 |
| K23AI157875 | Characterizing the virologic and immunologic signatures of HIV exceptional control | 2 | 2025 |
| P01CA108671 | Myeloproliferative Neoplasms-Research Consortium | 2 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
1 to 10 of 914Source NIH's project files
See all 914 nih grantsPapers1,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide transcriptomics and a machine learning-based random forest model identify novel biomarkers to predict phenotypic variability in Wilson disease. | Hum Immunol | 2026 | 42826579 | PubTator, text mining | PubMed |
| Microcytic Anemia with Low HbA2 and Normal HbA: Two Cases of Rare Thalassemia. | Hemoglobin | 2026 | 42655983 | PubTator, text mining | PubMed |
| Why Choline Chloride? A Comparative Study of Physicochemical Properties and Machine Learning-Driven Insights Into Melting Point Trends. | ChemSusChem | 2026 | 42622528 | PubTator, text mining | PubMed |
| Incidence and Laboratory Differentiation of Hb S/D-Punjab and Hb S/Korle-Bu in Newborn Screening in Minas Gerais, Brazil: A 10-Year Prospective Study. | Hemoglobin | 2026 | 42619451 | PubTator, text mining | PubMed |
| Genetic Analysis of Two Patients with Compound Thalassemia Presenting with Elevated HbF and Normal HbA2 Levels. | Hemoglobin | 2026 | 42509210 | PubTator, text mining | PubMed |
| Prenatal diagnosis of hemoglobinopathies by chorionic villus sampling: A large single-center experience. | Turk J Obstet Gynecol | 2026 | 42483976 | PubTator, text mining | PubMed |
| Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing. | Clin Chem | 2026 | 42335171 | PubTator, text mining | PubMed |
| Plasma proteomics identifies potential biomarkers of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. | J Clin Neurosci | 2026 | 42322686 | PubTator, text mining | PubMed |
| Identification and Validation of Hub Ferroptosis‑Related Genes in Sepsis: An Integrated Bioinformatics and Experimental Study. | Curr Mol Med | 2026 | 42257259 | PubTator, text mining | PubMed |
| Mutation Spectrum of Hemoglobinopathies in Tunisia. | Hum Mutat | 2026 | 42253506 | PubTator, text mining | PubMed |
1 to 10 of 1,868
See all 1,868 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/100187828
GET https://conductscience.org/api/genes/v1/100187828/grants?page=2